Coramaze raises €1.0M Seed round

12 February 2014· Hilden, Germany· health, medtech, biotech, b2b, deep_hardware

The company will use the funding to advance the pre-clinical development of its mitramaze valve repair system for the minimally invasive treatment of mitral regurgitation.

Investors

LeadHigh-Tech Gründerfonds

Also participating

SeedCapital Dortmund

About Coramaze

Stage

Series A

Headquarters

Hilden, Germany

Founded

2013

Team Size

21–50

Sectors

healthmedtechbiotechb2bdeep_hardware

http://coramaze.com/

Source: https://www.htgf.de/en/coramaze-technologies-gmbh-receives-e-1-million-to-develop-an-innovative-medical-device-for-the-minimally-invasive-treatment-of-heart-valve-diseases/